Tango Therapeutics TNGX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's operating lease right-of-use assets in other assets?
- Tango Therapeutics (TNGX) reported operating lease right-of-use assets in other assets of $34.65M in Q1 2026.
- How has Tango Therapeutics's operating lease right-of-use assets in other assets changed year-over-year?
- Tango Therapeutics's operating lease right-of-use assets in other assets decreased by 12.7% year-over-year, from $39.7M to $34.65M.
- What is the long-term trend for Tango Therapeutics's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Tango Therapeutics's operating lease right-of-use assets in other assets has grown at a 36.6% compound annual growth rate (CAGR), from $7.48M to $35.62M.